265 related articles for article (PubMed ID: 10805977)
1. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
3. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
Nak D; Nak Y; Cangul IT; Tuna B
J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
Scarpelli KC; Valladão ML; Metze K
Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
[TBL] [Abstract][Full Text] [Related]
5. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
7. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
8. Successful management of metastatic transmissible venereal tumour to skin of mammary region.
Varughese EE; Singla VK; Ratnakaran U; Gandotra VK
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():366-9. PubMed ID: 23279540
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs.
Marino G; Gaglio G; Zanghì A
J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831
[TBL] [Abstract][Full Text] [Related]
10. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
[TBL] [Abstract][Full Text] [Related]
11. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT).
Özalp GR; Zik B; Bastan A; Peker S; Özdemir-Salci ES; Bastan I; Darbaz I; Salar S; Karakas K
Biotech Histochem; 2012 Jul; 87(5):325-30. PubMed ID: 22404564
[TBL] [Abstract][Full Text] [Related]
12. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases.
Papazoglou LG; Koutinas AF; Plevraki AG; Tontis D
J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
Brown NO; Calvert C; MacEwen EG
J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
[TBL] [Abstract][Full Text] [Related]
14. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.
Mukaratirwa S; Chiwome T; Chitanga S; Bhebhe E
Vet Res Commun; 2006 Aug; 30(6):613-21. PubMed ID: 16838203
[TBL] [Abstract][Full Text] [Related]
15. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
Hiblu MA; Khabuli NM; Gaja AO
Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
[TBL] [Abstract][Full Text] [Related]
16. Transmissible venereal tumor: a retrospective study of 29 cases.
Rogers KS; Walker MA; Dillon HB
J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
[TBL] [Abstract][Full Text] [Related]
17. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
18. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
Holmes JM
Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
[TBL] [Abstract][Full Text] [Related]
19. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
Guvenc T; Haligur M; Orman MN; Haziroglu R
Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
[TBL] [Abstract][Full Text] [Related]
20. Semen quality during vincristine treatment in dogs with transmissible venereal tumor.
Saratsis P; Ypsilantis P; Tselkas K
Theriogenology; 2000 Mar; 53(5):1185-92. PubMed ID: 10798495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
